Chemical and Metabolic Profiling of Si-Ni Decoction Analogous Formulae by High performance Liquid Chromatography-Mass Spectrometry

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Chen, Qian ^a   Xiao, Shun ^a   Li, Zhenhao ^a   Ai, Ni ^a   Fan, Xiaohui ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; SINI TANG; XENOBIOTIC AGENT;

ANIMAL; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; PROCEDURES; REPRODUCIBILITY; SPRAGUE DAWLEY RAT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUGS, CHINESE HERBAL; MALE; MASS SPECTROMETRY; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; XENOBIOTICS;

EID: 84934274491     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11638     Document Type: Article

References (53)

1. Cho, W. C. Evidence-based anticancer materia medica. (Springer, 2011).
2. Jia, W. et al. The rediscovery of ancient Chinese herbal formulas. Phytother. Res. 18, 681-686 (2004).
3. Wu, H. F. et al. Recent developments in qualitative and quantitative analysis of phytochemical constituents and their metabolites using liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 72, 267-291 (2013).
4. Ipsen, A., Want, E. J. & Ebbels, T. M. Construction of confidence regions for isotopic abundance patterns in LC/MS data sets for rigorous determination of molecular formulas. Anal. Chem. 82, 7319-7328 (2010).
5. Wang, S., Chen, P., Xu, Y., Li, X. & Fan, X. Characterization of the chemical constituents in Da-Huang-Gan-Cao-Tang by liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and liquid chromatography coupled with ion trap mass spectrometry. Journal of separation science 37, 1748-1761, doi: 10.1002/jssc.201400061 (2014).
6. Lv, Y. et al. Characterization of the constituents in rat biological fluids after oral administration of Fufang Danshen tablets by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Journal of pharmaceutical and biomedical analysis 52, 155-159, doi: 10.1016/j.jpba.2009.12.013 (2010).
7. Yan, Y. et al. HPLC-DAD-Q-TOF-MS/MS analysis and HPLC quantitation of chemical constituents in traditional Chinese medicinal formula Ge-Gen Decoction. Journal of pharmaceutical and biomedical analysis 80, 192-202, doi: 10.1016/j. jpba.2013.03.008 (2013).
8. Zhang, H.-Y. et al. Screening and identification of multi-component in Qingkailing injection using combination of liquid chromatography/time-of-flight mass spectrometry and liquid chromatography/ion trap mass spectrometry. Analytica chimica acta 577, 190-200 (2006).
9. Lu, Q. & Jiang, J.-G. Chemical metabolism of medicinal compounds from natural botanicals. Current medicinal chemistry 19, 1682-1705 (2012).
10. Wang, Q. et al. Identification and pharmacokinetics of multiple constituents in rat plasma after oral administration of Yinchenzhufu decoction. J. Ethnopharmacol. 153, 714-724 (2014).
11. Wang, X. J. et al. Pharmacokinetics screening for multi-components absorbed in the rat plasma after oral administration traditional Chinese medicine formula Yin-Chen-Hao-Tang by ultra performance liquid chromatography-electrospray ionization/ quadrupole-time-of-flight mass spectrometry combined with pattern recognition methods. Analyst 136, 5068-5076 (2011).
12. Tan, G. Q. et al. Metabonomic profiles delineate the effect of traditional Chinese medicine Sini decoction on myocardial infarction in rats. PLoS One 7, e34157 (2012).
13. Su, H. F., Zou, R., Liu, Y. & Li, X. Study the efficacy of SiNi Jia RenShen broth treatment in patients with silent myocardial ischemia (SMI) after subacute myocardial infarction. Chinese Archives of Traditional Chinese Medicine 23, 1415-1417 (2004).
14. Liu, J. Q. et al. Anti-Inflammatory Effects of the Chinese Herbal Formula Sini Tang in Myocardial Infarction Rats. Evid. Based Complement. Alternat. Med. 2014, 309378 (2014).
15. Jin, M. H., Qin, J. & Wu, W. K. Clinical Study on "Sini" Decoction in Treating Stenocardia for Coronary Heart Disease. Zhong Yao Cai. 1, 030 (2003).
16. Tan, G. G. et al. Characterization of constituents in Sini decoction and rat plasma by high-performance liquid chromatography with diode array detection coupled to time-of-flight mass spectrometry. Biomed. Chromatogr. 25, 913-924 (2011).
17. Xiao, S., Luo, K. D., Wen, X. X., Fan, X. H. & Cheng, Y. Y. A pre-classification strategy for identification of compounds in traditional Chinese medicine analogous formulas by high-performance liquid chromatography-Mass spectrometry. J. Pharm. Biomed. Anal. 92, 82-89 (2014).
18. Wang, S. et al. Fragment ion diagnostic strategies for the comprehensive identification of chemical profile of Gui-Zhi-Tang by integrating high-resolution MS, multiple-stage MS and UV information. Journal of pharmaceutical and biomedical analysis 98, 22-35 (2014).
19. Zheng, C. et al. Diagnostic fragment-ion-based extension strategy for rapid screening and identification of serial components of homologous families contained in traditional Chinese medicine prescription using high-resolution LC-ESI-IT-TOF/MS: Shengmai injection as an example. Journal of Mass Spectrometry 44, 230-244 (2009).
20. Chen, Y., Koelliker, S., Oehme, M. & Katz, A. Isolation of Diterpenoid Alkaloids from Herb and Flowers of Aconitum n apellus ssp. v ulgare and Electrospray Ion Trap Multiple MS Study of These Alkaloids. J. Nat. Prod. 62, 701-704 (1999).
21. Wang, F. P., Chen, Q. H. & Liu, X. Y. Diterpenoid alkaloids. Nat. Prod. Rep. 27, 529-570 (2010).
22. Tan, G. G. et al. Detection and identification of diterpenoid alkaloids, isoflavonoids and saponins in Qifu decoction and rat plasma by liquid chromatography-time-of-flight mass spectrometry. Biomed. Chromatogr. 26, 178-191 (2012).
23. Sun, H. et al. Pharmacokinetic study of schisandrin, schisandrol B, schisantherin A, deoxyschisandrin, and schisandrin B in rat plasma after oral administration of Shengmaisan formula by UPLC-MS. J. Sep. Sci. 36, 485-491 (2013).
24. Singhuber, J., Zhu, M., Prinz, S. & Kopp, B. Aconitum in Traditional Chinese Medicine-valuable drug or an unpredictable risk? J. Ethnopharmacol. 126, 18-30 (2009).
25. Liou, S. S., Liu, I. M. & Lai, M. C. The plasma glucose lowering action of Hei-Shug-Pian, the fire-processed product of the root of Aconitum (Aconitum carmichaeli), in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 106, 256-262 (2006).
26. Shaheen, F. et al. Alkaloids of Aconitum laeve and their anti-inflammatory, antioxidant and tyrosinase inhibition activities. Phytochemistry. 66, 935-940 (2005).
27. Zhao, D., Wang, J., Cui, Y. & Wu, X. Pharmacological effects of Chinese herb aconite (fuzi) on cardiovascular system. Journal of Traditional Chinese Medicine 32, 308-313 (2012).
28. Huang, H., Zhu, B. & Huang, B. Effect of aconite decoction on BNP, IL-6 levels in chronic congestive heart failure rats model. Shan Xi Zhong Yi 30, 745-746 (2009).
29. Niu, C., Zhang, T., Xu, H. & Qin, X. Research of vasodilation effect of aconite decoction on the rabbit aorta in vitro. Zhong Yao Yao Li Yu Lin Chuang 20, 23-25 (2004).
30. Pyo, M. K. et al. Effects of higenamine and its 1-naphthyl analogs, YS-49 and YS-51, on platelet TXA 2 synthesis and aggregation. Thrombosis research 120, 81-86 (2007).
31. Wang, Y. C. & Yang, Y. S. Simultaneous quantification of flavonoids and triterpenoids in licorice using HPLC. J. Chromatogr. B. 850, 392-399 (2007).
32. Jayaprakasam, B. et al. Licorice flavonoids inhibit eotaxin-1 secretion by human fetal lung fibroblasts in vitro. J. Agric. Food. Chem. 57, 820-825 (2009).
33. Yang, N. et al. Glycyrrhiza uralensis Flavonoids Present in Anti-Asthma Formula, ASHMITM, Inhibit Memory Th2 Responses in Vitro and in Vivo. Phytother. Res. 27, 1381-1391 (2013).
34. Honda, H. et al. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor Toll-like receptor 4/MD-2 complex signaling in a different manner. J. Leukoc. Biol. 91, 967-976 (2012).
35. Fukai, T. et al. Anti-Helicobacter pylori flavonoids from licorice extract. Life sciences 71, 1449-1463 (2002).
36. Asl, M. N. & Hosseinzadeh, H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytotherapy Research 22, 709-724 (2008).
37. Zhang, B. K. & Fang, L. Q. Modern Clinical Application of Pulvis Fellis Suis. Chinese Traditional Patent Medicine 36, 376-379 (2014).
38. He, J. et al. Anti-inflammatory effects of Pulvis Fellis Suis extract in mice with ulcerative colitis. J. Ethnopharmacol. 138, 53-59 (2011).
39. He, J. et al. Protective effect of taurohyodeoxycholic acid from Pulvis Fellis Suis on trinitrobenzene sulfonic acid induced ulcerative colitis in mice. Eur. J. Pharmacol. 670, 229-235 (2011).
40. Sciutto, A. M., Colombo, P. & Germogli, R. The new biliary acid taurohyodeoxycholic acid in the treatment of gallstones. Acta Toxicologica et Therapeutica 17, 323-338 (1996).
41. Liu, M. et al. Effects of taurochenodeoxycholic acid on adjuvant arthritis in rats. International immunopharmacology 11, 2150-2158 (2011).
42. Epstein, F. H. & Ross, R. Atherosclerosis-An inflammatory disease. New England journal of medicine 340, 115-126 (1999).
43. Mathieu, P., Lemieux, I. & Despres, J. Obesity, inflammation, and cardiovascular risk. Clinical Pharmacology & Therapeutics 87, 407-416 (2010).
44. Gao, X.-M. et al. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: A predominant role of anti-inflammation. Journal of molecular and cellular cardiology 50, 991-999 (2011).
45. Guo, J., Lin, G.-s., Bao, C.-y., Hu, Z.-m. & Hu, M.-y. Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction. Inflammation 30, 97-104 (2007).
46. Libby, P. & Crea, F. Clinical implications of inflammation for cardiovascular primary prevention. European heart journal 31, 777-783 (2010).
47. Yan, B. et al. Construction of the fingerprints of ginseng stem and leaf saponin reference substances and spiked plasma sample by LC-ESI/MS and its application to analyzing the compounds absorbed into blood after oral administration of ginseng stem and leaf saponin in rat. Biol. Pharm. Bull. 30, 1657-1662 (2007).
48. Qi, L. W., Wang, C. Z. & Yuan, C. S. Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry 72, 689-699 (2011).
49. Van Kampen, J. M., Baranowski, D. B., Shaw, C. A. & Kay, D. G. Panax ginseng is neuroprotective in a novel progressive model of Parkinsons disease. Exp. Gerontol. 50, 95-105 (2014).
50. Karmazyn, M., Moey, M. & Gan, X. T. Therapeutic potential of ginseng in the management of cardiovascular disorders. Drugs 71, 1989-2008 (2011).
51. Wang, Z., Li, M., Wu, W.-k., Tan, H.-m. & Geng, D.-f. Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction. Cardiovascular Drugs and Therapy 22, 443-452 (2008).
52. Jiang, Q. S., Huang, X. N. & Jiang, X. Y. Inhibitory effect of ginsenoside Rb1 on calcineurin signal pathway in cardiomyocyte hypertrophy induced by prostaglandin F2α 1. Acta pharmacologica sinica 28, 1149-1154 (2007).
53. Ni, S. et al. UPLC-QTOF/MS-based screening and identification of the constituents and their metabolites in rat plasma and urine after oral administration of Glechoma longituba extract. Journal of Chromatography B 878, 2741-2750 (2010).